Direct Stenting in ST Segment Elevation Myocardial Infarction: Are We There Yet?

Affiliations

¹ Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, United States.
² Keele Cardiovascular Research Group, Center for Prognosis Research, Keele University, United Kingdom; Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

Editorial

Harsh Golwala et al. Cardiovasc Revasc Med. 2022 Aug.

. 2022 Aug:41:151-153.

doi: 10.1016/j.carrev.2022.05.023. Epub 2022 May 19.

¹ Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, United States.
² Keele Cardiovascular Research Group, Center for Prognosis Research, Keele University, United Kingdom; Department of Cardiology, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

No abstract available

Conflict of interest statement

Declaration of competing interest HG serves as an advisory consultant to Medtronic and Boston Scientific.

Very Long-Term Clinical Outcomes After Direct Stenting in Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Scarparo P, Improta R, Wilschut J, Kardys I, Den Dekker WK, Daemen J, Zijlstra F, Van Mieghem NM, Diletti R. Scarparo P, et al. Cardiovasc Revasc Med. 2022 Aug;41:144-150. doi: 10.1016/j.carrev.2022.01.014. Epub 2022 Jan 19. Cardiovasc Revasc Med. 2022. PMID: 35074298